• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝表面抗原抑制浆细胞样树突状细胞中Toll样受体9介导的激活作用及α干扰素的产生。

HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.

作者信息

Xu Yongfen, Hu Yunwen, Shi Bisheng, Zhang Xiaonan, Wang Jiefei, Zhang Zhanqing, Shen Fang, Zhang Qin, Sun Shuhui, Yuan Zhenghong

机构信息

Fudan University, China.

出版信息

Mol Immunol. 2009 Aug;46(13):2640-6. doi: 10.1016/j.molimm.2009.04.031. Epub 2009 Jun 5.

DOI:10.1016/j.molimm.2009.04.031
PMID:19501403
Abstract

Plasmacytoid dendritic cells (pDCs), the professional producers of type I interferons (IFN-alpha/beta), play a pivotal role in innate and adaptive immune responses against viral infections. Although functional impairment of circulating pDCs in chronic hepatitis B (CHB) patients has been reported previously, the mechanism responsible for these defects remains unclear. We hypothesize that HBsAg circulating in high amounts during HBV infection may interact with pDC and contribute to pDC dysfunction. In support of this hypothesis we show that pDCs treated with HBsAg secreted much less IFN-alpha than control pDCs. Furthermore, suppression is specific for TLR9, with no effects upon TLR7-mediated IFN-alpha secretion. HBsAg inhibited TLR9-mediated IRF-7 expression and nuclear translocation, which are important for induction of IFN-alpha gene transcription. HBsAg upregulated the SOCS-1 expression and bound to BDCA-2 receptors on the plasma membrane of pDCs, resulting in the inhibition of the IFN-alpha production. In conclusion, the above data suggested that HBsAg may directly interfere with the function of pDC through HBsAg-mediated upregulation of SOCS-1 expression and BDCA-2 ligation, which could partially explain how HBV evades the immune system to establish a persistent infection.

摘要

浆细胞样树突状细胞(pDC)是I型干扰素(IFN-α/β)的主要产生细胞,在针对病毒感染的固有免疫和适应性免疫反应中起关键作用。尽管先前已有报道慢性乙型肝炎(CHB)患者循环pDC功能受损,但其缺陷的机制仍不清楚。我们推测,HBV感染期间大量循环的HBsAg可能与pDC相互作用并导致pDC功能障碍。支持这一假设的是,我们发现用HBsAg处理的pDC分泌的IFN-α比对照pDC少得多。此外,这种抑制作用对TLR9具有特异性,对TLR7介导的IFN-α分泌没有影响。HBsAg抑制TLR9介导的IRF-7表达和核转位,这对IFN-α基因转录的诱导很重要。HBsAg上调SOCS-1表达并与pDC质膜上的BDCA-2受体结合,导致IFN-α产生受到抑制。总之,上述数据表明,HBsAg可能通过HBsAg介导的SOCS-1表达上调和BDCA-2连接直接干扰pDC的功能,这可以部分解释HBV如何逃避免疫系统以建立持续感染。

相似文献

1
HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.乙肝表面抗原抑制浆细胞样树突状细胞中Toll样受体9介导的激活作用及α干扰素的产生。
Mol Immunol. 2009 Aug;46(13):2640-6. doi: 10.1016/j.molimm.2009.04.031. Epub 2009 Jun 5.
2
Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.一种小分子合成TLR7配体对TLR9介导的IFN-α诱导的负调控
J Leukoc Biol. 2007 Sep;82(3):497-508. doi: 10.1189/jlb.0906575. Epub 2007 Jun 12.
3
Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.布鲁顿酪氨酸激酶调控人浆细胞样树突状细胞中的TLR9信号通路,但不调控TLR7信号通路。
Eur J Immunol. 2014 Apr;44(4):1130-6. doi: 10.1002/eji.201344030. Epub 2014 Jan 20.
4
Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.Rac 激活蛋白 DOCK2 对 TLR 介导的浆细胞样树突状细胞活化中 I 型 IFN 诱导的选择性控制。
J Exp Med. 2010 Apr 12;207(4):721-30. doi: 10.1084/jem.20091776. Epub 2010 Mar 15.
5
HBsAg inhibits IFN-α production in plasmacytoid dendritic cells through TNF-α and IL-10 induction in monocytes.HBsAg 通过诱导单核细胞产生 TNF-α 和 IL-10 抑制浆细胞样树突状细胞产生 IFN-α。
PLoS One. 2012;7(9):e44900. doi: 10.1371/journal.pone.0044900. Epub 2012 Sep 14.
6
TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.Toll样受体9/ Toll样受体7触发健康个体和狼疮患者的人浆细胞样树突状细胞上BDCA2表达的下调。
Clin Immunol. 2008 Oct;129(1):40-8. doi: 10.1016/j.clim.2008.06.004. Epub 2008 Aug 5.
7
Inhibitory effects of human immunodeficiency virus gp120 and Tat on CpG-A-induced inflammatory cytokines in plasmacytoid dendritic cells.人免疫缺陷病毒 gp120 和 Tat 对浆细胞样树突状细胞中 CpG-A 诱导的炎症细胞因子的抑制作用。
Acta Biochim Biophys Sin (Shanghai). 2012 Sep;44(9):797-804. doi: 10.1093/abbs/gms062. Epub 2012 Jul 19.
8
Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.邻苯二甲酸酯通过表观遗传调控抑制人浆细胞样树突状细胞的 I 型干扰素。
Allergy. 2013 Jul;68(7):870-9. doi: 10.1111/all.12162. Epub 2013 Jun 5.
9
Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B.TLR7/9 的下调导致慢性乙型肝炎中浆细胞样树突状细胞产生 IFN-α不足。
Inflamm Res. 2012 Sep;61(9):997-1004. doi: 10.1007/s00011-012-0493-z. Epub 2012 Jun 10.
10
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.HIV-1 gp120抑制浆细胞样树突状细胞中TLR9介导的激活及IFN-α分泌。
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401. doi: 10.1073/pnas.0611353104. Epub 2007 Feb 20.

引用本文的文献

1
Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection.抗乙肝病毒治疗可部分恢复慢性乙肝病毒感染过程中固有免疫细胞和非常规T细胞的功能障碍。
Front Immunol. 2025 Jul 4;16:1611976. doi: 10.3389/fimmu.2025.1611976. eCollection 2025.
2
Ubiquitin-dependent proteasomal degradation of small hepatitis B virus surface antigen mediated by TRIM21 and antagonized by OTUD4.由TRIM21介导且被OTUD4拮抗的小乙肝病毒表面抗原的泛素依赖性蛋白酶体降解
J Virol. 2025 May 20;99(5):e0230924. doi: 10.1128/jvi.02309-24. Epub 2025 Apr 25.
3
Innate immune recognition in hepatitis B virus infection.
乙型肝炎病毒感染中的固有免疫识别
Virulence. 2025 Dec;16(1):2492371. doi: 10.1080/21505594.2025.2492371. Epub 2025 Apr 20.
4
Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma.乙型肝炎表面抗原:在肝细胞癌中的致癌机制及临床意义
Exp Hematol Oncol. 2025 Mar 26;14(1):44. doi: 10.1186/s40164-025-00642-7.
5
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0.慢性乙型肝炎功能性治愈的治疗导航更新:专家共识2.0
Clin Mol Hepatol. 2025 Feb;31(Suppl):S134-S164. doi: 10.3350/cmh.2024.0780. Epub 2025 Jan 22.
6
Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV.干扰素清除HBV临床疗效受损的潜在机制。
Virol J. 2024 Dec 4;21(1):314. doi: 10.1186/s12985-024-02589-3.
7
Hepatitis B surface antigen impairs TLR4 signaling by upregulating A20 expression in monocytes.乙型肝炎表面抗原通过上调单核细胞中 A20 的表达来抑制 TLR4 信号通路。
Microbiol Spectr. 2024 Oct 3;12(10):e0090924. doi: 10.1128/spectrum.00909-24. Epub 2024 Sep 9.
8
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.浆细胞样树突状细胞的抑制性受体作为癌症检查点阻断治疗的潜在靶点。
Front Immunol. 2024 Mar 5;15:1360291. doi: 10.3389/fimmu.2024.1360291. eCollection 2024.
9
The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges.中医药在抗乙肝病毒中的作用:背景、进展与挑战
Chin Med. 2023 Dec 2;18(1):159. doi: 10.1186/s13020-023-00861-2.
10
The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.先天免疫系统在 mRNA 治疗有效性中的双重作用。
Int J Mol Sci. 2023 Oct 1;24(19):14820. doi: 10.3390/ijms241914820.